Overall, our study shows that the development of CRS requires the involvement of multiple immune cells, and IL-2, TNF-α, and IFN-γ may act as the primary factors in triggering CRS, providing promising avenues for clinical interventions for patients with COVID-19. This evidence concerns the gene IL2 and congenital rubella syndrome.